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Primary tumors of the heart and major vessels are rare. Angiosarcoma is the most frequent malignant
tumor of the heart and usually involves the right atrium. Angiosarcoma originating from the pericardium
is extremely rare and only several cases have been reported to date. The current study presents a case of
primary angiosarcoma of pericardium with cardiac tamponade. After surgical treatment to relieve
symptoms, the patient refused further therapies and died 3 months after diagnosis.
Copyright © 2015, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Primary malignant tumors of the heart and major vessels are
rare. Amongst the malignant tumors of the heart, angiosarcoma is
the most common and accounts for more than two thirds of these
malignancies1,2. Angiosarcoma frequently involve the cardiac
chambers, especially the right atrium. However, detection of
angiosarcoma of the pericardium is very rare3. The clinical pre-
sentation of pericardial angiosarcoma depends on the location of
involvement rather than histological type. The prognosis for a pa-
tient with angiosarcoma is poor with an overall survival duration of
between 6 months and 12 months even under multi-modality
treatments1. Patient outcome is improved if chemotherapy is
applied after surgical resection. There are several reports of pa-
tients' surviving up to 40 months.2. Case report
An 83-year-old male patient presented with a history of atrial
ﬁbrillation, chronic ischemic heart disease, and congestive heart
failure, for several years. He received regular medical control at out-re that they have no conﬂicts
sion, Department of Internal
hun-Shan North Road, Taipei,
tric Emergency & Critical Care Mepatient clinics. Oneweek before admission, progressive dyspnea on
exertion, a dry cough, and a worsened low leg edemawere present.
He was brought to the out-patients department for ﬁrst aid. A chest
X-ray revealed a huge, bottle-shaped heart shadow (Fig. 1). Elec-
trocardiogram revealed atrial ﬁbrillation with diffuse low voltage
amplitude. Routine laboratory studies were normal. Radiological
ﬁndings indicated pericardial tamponade. An emergency trans-
thoracic echocardiogram was arranged and showed a massive
pericardial effusion with cardiac tamponade. Pericardiocentesis
and drainage were performed and 500 mL hemorrhagic pericardial
ﬂuid was drained. The patient's symptoms were rapidly relieved.
Cytological and bacterial examinations of the pericardial effusions
were all negative. Chest computerized tomography (CT) was ar-
ranged on suspicion of a malignant tumor, and showed a
4.7 cm  2.5 cm soft tissue nodule present at the pericardial space
along the left atrioventricular groove. A 3 cm 1.5 cm lesion next to
the lateral wall of the left ventricular wall associated with mild
pericardial effusion, and multiple mediastinal lymphadenopathy
was also detected (Fig. 2). A positron emission tomography (PET)
scan further conﬁrmed a pericardial malignancy with mediastinal
lymph node metastasis (Fig. 3). Surgical resection of the pericardial
tumor was later performed. The pathology indicated multiple
nodular proliferations on the pericardium. Tumor cells were
strongly positive for CD31; weakly positive for WT-1; and negative
for cytokeratin (AE1/AE3), HMB-45, and S-100 (Fig. 4). All these
ﬁndings are consistent with angiosarcoma. Adjuvant chemotherapy
and radiation therapies were recommended but the patient refused
all treatments. He died following tumor recurrence 3 months later.dicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Chest X-ray reveals bottle-shaped and enlarged heart size.
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Primary cardiac tumors are rare; their incidence was estimated
to be 0.0017e0.003% in a study of routine autopsy1. The majority of
cardiac tumors are benign with myxoma being the most common
benign tumor of the heart (50%), followed by lipoma (~25%)4.Fig. 2. A computed tomography scan reveals a 4.7 cm  2.5 cm soft tissue nodule
present in the pericardial space along the left atrioventricular groove with mild
pericardial effusion.Malignant cardiac tumors are estimated to account for 25% of all
cardiac tumors5. Angiosarcoma is the most frequent malignant
tumor of the heart. Malignant cardiac tumors frequently tend to
involve the pericardium and right heart chambers, especially the
posterior wall of the right atrium, as was seen in a report of 119
cases by Meng et al4. The prevalence does not differ by sex1,
however; a greater tendency was reported in male patients6.
Angiosarcoma is the most common malignant tumor of the
heart and its incidence is estimated to be about 31% of all malignant
tumors. Angiosarcoma tends to occur in people aged 30e50 years.
The initial diagnosis of angiosarcoma is usually delayed because of
its nonspeciﬁc characteristics and detection depends on the sur-
gical biopsy of tumors. Symptoms of angiosarcoma include dys-
pnea, chest discomfort, heart failure, palpitations, and general
weakness. The most common site of involvement is the right
atrium, followed by left atrium, right ventricle, and left ventricle7.
Metastasis is about 80% when angiosarcoma is diagnosed. The
lungs, mediastinal lymph nodes, and vertebrae are the most com-
mon metastatic sites.
A chest radiograph may disclose cardiomegaly, pulmonary
congestion, or pericardial effusion. Transthoracic echocardiography
is also an important tool used to detect cardiac tumors. Trans-
esophageal echocardiographymight have better ability to delineate
the tumor location and the severity of local inﬁltration. Chest CT is
useful to identify metastasis. Cytological analysis of pericardial
effusion is also helpful; with the positive rate ranging from 75% to
87%.A transvenous endocardial biopsy procedure was reported in
one study8. Despite all the abovemethods, surgical biopsy is always
necessary to yield an adequate sample for diagnosis. Immunohis-
tochemical stains are positive for CD31, CD34, and Factor VIII, which
are characteristic features of vascular origin.
The overall average survival time is between 6 months and 12
months. Rare cases may survive up to 2e4 years. Tumor staging of
cardiac angiosarcoma is currently not available, which may be due
to its rarity. There is also a lack of large studies to compare the
effects of different therapies in combination. Surgical resection
remains important in order to examine the tissue and for rapid
relief of symptoms. Even though total surgical resection is the
treatment of choice, recurrence is common6. Angiosarcoma
generally responds poorly to chemotherapy. The most frequently
used chemotherapy drugs include Adriamycin, ifosfamide, cyclo-
phosphamide, vincristine, and dacarbazine. There are not many
studies comparing different chemotherapeutic regimens because of
the rarity of cardiac angiosarcoma. Adriamycin-based regimens are
the most commonly used regimens by oncologists. Pegylated
liposomal doxorubicin has been used for the treatment of Kaposi's
sarcoma in AIDS, its use was also reported for the treatment of
angiosarcoma in one study9. Both Kaposi's sarcoma and angio-
sarcoma are tumors of the endothelial cells and may share some
biological properties10. Recently, paclitaxel combined with lipo-
somal doxorubicin has also been reported to demonstrate favorable
results in the treatment of angiosarcoma11. Even though the overall
response is poor with chemotherapy, patients treated with
chemotherapy had better survival outcomes than did thosewithout
chemotherapy12. Adjuvant radiotherapy has a limited role of ther-
apy due to its cardiotoxicity. It may play a role in patients with brain
metastasis or superior vena cava syndromes13. Patients who avail of
multidisciplinary therapies survived longer than those who were
treated with a single therapy6,12. Overall survival may be up to 19
months in patients who undergo surgical resection and chemo-
therapy. Orthotopic cardiac transplantation has been tried in rare
cases of angiosarcoma but patient survival did not differ from those
without transplantation14.
In conclusion, pericardial tamponade is an emergent medical
condition which could be caused by a number of systemic diseases
Fig. 3. The F-18 FDG whole body positron emission tomography scan reveals pericardial malignancy with mediastinal lymph nodes metastasis.
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Fig. 4. (A, B) Pathology shows the tumor is composed of spindle to pleomorphic cells; (C) immunohistochemical staining is positive for CD31; and (D) immunohistochemical
staining is negative for cytokeratin (AE1/AE3).
Primary Angiosarcoma of Pericardium with Cardiac Tamponade 129such as uremia or cancer to name but a few. Apart from metastatic
cancers, primary cardiac tumors, including pericardial angio-
sarcoma, should also be suspected. Although the outcome of
angiosarcoma is poor, multiple modalities therapies, including
surgical resection, chemotherapy, and radiotherapy, should be
considered to prolong survival time.
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